• 6 months ago
During a House Oversight Committee hearing on Thursday, Rep. Jamie Raskin (D-MD) gave opening remarks about the FDA.

Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:

https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript


Stay Connected
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com

Category

🗞
News
Transcript
00:00I now yield to Ranking Member Raskin for his opening statement.
00:05Thank you very much, Mr. Chairman, and thank you to Commissioner Dr. Kalaf for being with
00:10us here today.
00:13The FDA regulates everything from bottled water to infant formula, meat, poultry and
00:19egg products, prescription and non-prescription drugs, vaccines, medical devices, microwaves,
00:27dental care products and tobacco.
00:30During the Biden-Harris administration, the FDA has made critical progress to ensure that
00:36we have access to safer food and to effective drugs.
00:40For example, last fall FDA acted quickly to investigate reports of lead appearing in children's
00:48cinnamon applesauce packets for their school lunch.
00:53The cinnamon was adulterated with lead, which was added by the manufacturer in order to
01:01increase the weight of the product to make it more profitable in the process.
01:08However, the applesauce contamination issue could have been completely prevented if end
01:15product inspections for food were required.
01:19The FDA asked Congress to amend the Food, Drug and Cosmetic Act as part of the FY 2024
01:27budget request to require that industry conduct testing of final products exactly for such
01:33contaminants and provide FDA immediate access to those results.
01:38This would greatly help to ensure the safety of all of our food products for kids and for
01:43everyone else.
01:45But the FDA needs these additional authorities to make that happen.
01:51And, Mr. Chairman, I was very pleased to hear your opening comments, and I hope you would
01:55join me in supporting giving the FDA additional regulatory authority precisely to address
02:02the kinds of problems that both you and I have identified.
02:06The FDA itself has proposed multiple solutions that would address the problems we are talking
02:11about today.
02:12The Democrats support greater and more refined regulatory authority to make our food and
02:18drugs safer, and we hope our colleagues will join us.
02:22In the wake of infant formula and prescription drug shortages, FDA also advanced legislative
02:29proposals earlier this year to strengthen notification requirements and data sharing.
02:35Right now, they don't have any authority to tell drug manufacturers to produce more drugs.
02:41One proposal they have offered would require manufacturers to notify the FDA, dealing with
02:49this first problem of the applesauce, would require manufacturers to notify FDA about
02:54pathogens that are discovered in certain critical foods.
02:58In the case of infant formula, this authority would help FDA prevent contaminated infant
03:04formula from reaching any more consumers and babies.
03:08The second proposal they have suggested would expand FDA's authority to gather data from
03:13industry about potential drug shortages and supply chain disruptions.
03:20FDA has improved access to contraception and protections for medication abortion access.
03:27In 2021, FDA advanced the accessibility of medication abortion by removing the in-person
03:33dispensing requirement for mifepristone and allowing it to be distributed by mail through
03:38retail pharmacies.
03:39In July 2023, FDA approved the first over-the-counter birth control pill, Opil.
03:46As a result, consumers' access to contraception is improved at a critical time when many States
03:51are enacting increasingly draconian and oppressive abortion restrictions.
03:57FDA has also made advancements to combat a range of life-threatening diseases.
04:02In March of last year, FDA approved the first OTC opioid overdose reversal medication, Naloxone
04:10nasal spray, a critical step towards reducing opioid overdose deaths in our districts.
04:17FDA also recently approved new genome editing technologies to treat sickle cell anemia,
04:22a disease that has ravaged a lot of communities, primarily African Americans.
04:29This advancement is a crucial step towards treating sickle cell anemia and represents
04:33a breakthrough in gene therapy.
04:35FDA also secured additional supply chains in the wake of cancer drug shortages.
04:41It's crucial that FDA continue to carry out its mission and create meaningful regulations
04:46based on sound science and not conspiracy theories or ideological programs.
04:52Public attacks on FDA without any corresponding legislative solution simply undermine its
04:58ability to effectively protect public health.
05:03Antiabortion activists brought a case against FDA over its updated guidance on mifepristone,
05:07the first of a two-pill medication abortion.
05:10The activists claimed that FDA did not properly collect data on drug risks and complications.
05:16However, this claim is contrary to the FDA's review of, quote, extensive research showing
05:22that mifepristone is safe, including to take at home, unquote.
05:26FDA followed its standard procedure in reaching that conclusion, and according to the FDA,
05:31it must act reasonably based on the information available rather than act based on perfect
05:36data which seldom exists.
05:38If the objective of antiabortion activists is to undermine FDA's authority, the consequences
05:44will be devastating to public health.
05:45An FDA that bases its decisions on political science rather than actual science is not
05:51in the best interest of consumers.
05:53Congress must ensure that FDA is empowered to rely on the facts rather than bend to the
05:57will of people pushing an ideological agenda.
06:00Thank you, Mr. Chairman, and I yield back.

Recommended